175 related articles for article (PubMed ID: 35092510)
1. ErbB2 promotes breast cancer metastatic potential via HSF1/LDHA axis-mediated glycolysis.
He L; Lv S; Ma X; Jiang S; Zhou F; Zhang Y; Yu R; Zhao Y
Med Oncol; 2022 Jan; 39(4):45. PubMed ID: 35092510
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth.
Zhao YH; Zhou M; Liu H; Ding Y; Khong HT; Yu D; Fodstad O; Tan M
Oncogene; 2009 Oct; 28(42):3689-701. PubMed ID: 19668225
[TBL] [Abstract][Full Text] [Related]
3. Anticancer Effects of Cinnamaldehyde Through Inhibition of ErbB2/HSF1/LDHA Pathway in 5637 Cell Line of Bladder Cancer.
Aminzadeh Z; Ziamajidi N; Abbasalipourkabir R
Anticancer Agents Med Chem; 2022; 22(6):1139-1148. PubMed ID: 34315398
[TBL] [Abstract][Full Text] [Related]
4. HER2/ErbB2 activates HSF1 and thereby controls HSP90 clients including MIF in HER2-overexpressing breast cancer.
Schulz R; Streller F; Scheel AH; Rüschoff J; Reinert MC; Dobbelstein M; Marchenko ND; Moll UM
Cell Death Dis; 2014 Jan; 5(1):e980. PubMed ID: 24384723
[TBL] [Abstract][Full Text] [Related]
5. p53/Lactate dehydrogenase A axis negatively regulates aerobic glycolysis and tumor progression in breast cancer expressing wild-type p53.
Zhou Y; Niu W; Luo Y; Li H; Xie Y; Wang H; Liu Y; Fan S; Li Z; Xiong W; Li X; Ren C; Tan M; Li G; Zhou M
Cancer Sci; 2019 Mar; 110(3):939-949. PubMed ID: 30618169
[TBL] [Abstract][Full Text] [Related]
6. ErbB2-upregulated HK1 and HK2 promote breast cancer cell proliferation, migration and invasion.
Ma X; Chen J; Huang B; Fu S; Qu S; Yu R; Zhao Y
Med Oncol; 2023 Apr; 40(5):154. PubMed ID: 37079118
[TBL] [Abstract][Full Text] [Related]
7. Prognostic and therapeutic relevance of phosphofructokinase platelet-type (PFKP) in breast cancer.
Umar SM; Kashyap A; Kahol S; Mathur SR; Gogia A; Deo SVS; Prasad CP
Exp Cell Res; 2020 Nov; 396(1):112282. PubMed ID: 32919954
[TBL] [Abstract][Full Text] [Related]
8. miR-30a-5p suppresses breast tumor growth and metastasis through inhibition of LDHA-mediated Warburg effect.
Li L; Kang L; Zhao W; Feng Y; Liu W; Wang T; Mai H; Huang J; Chen S; Liang Y; Han J; Xu X; Ye Q
Cancer Lett; 2017 Aug; 400():89-98. PubMed ID: 28461244
[TBL] [Abstract][Full Text] [Related]
9. Overcoming trastuzumab resistance in breast cancer by targeting dysregulated glucose metabolism.
Zhao Y; Liu H; Liu Z; Ding Y; Ledoux SP; Wilson GL; Voellmy R; Lin Y; Lin W; Nahta R; Liu B; Fodstad O; Chen J; Wu Y; Price JE; Tan M
Cancer Res; 2011 Jul; 71(13):4585-97. PubMed ID: 21498634
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation-mediated activation of LDHA promotes cancer cell invasion and tumour metastasis.
Jin L; Chun J; Pan C; Alesi GN; Li D; Magliocca KR; Kang Y; Chen ZG; Shin DM; Khuri FR; Fan J; Kang S
Oncogene; 2017 Jul; 36(27):3797-3806. PubMed ID: 28218905
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of SCD1 by ErbB2 via LDHA promotes breast cancer cell migration and invasion.
Chen J; Lv S; Huang B; Ma X; Fu S; Zhao Y
Med Oncol; 2022 Dec; 40(1):40. PubMed ID: 36471172
[TBL] [Abstract][Full Text] [Related]
12. [Effect of LDHA Knockdown by siRNA on Migration and Invasion of ErbB2 Overexpressing Breast Cancer Cell Line].
He L; Li ML; Shen Y; Ma XJ; Yu R; Zhao YH
Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 Jan; 50(1):55-60. PubMed ID: 31037905
[TBL] [Abstract][Full Text] [Related]
13. FASN, ErbB2-mediated glycolysis is required for breast cancer cell migration.
Zhou L; Jiang S; Fu Q; Smith K; Tu K; Li H; Zhao Y
Oncol Rep; 2016 May; 35(5):2715-22. PubMed ID: 26936618
[TBL] [Abstract][Full Text] [Related]
14. The miR-34a-LDHA axis regulates glucose metabolism and tumor growth in breast cancer.
Xiao X; Huang X; Ye F; Chen B; Song C; Wen J; Zhang Z; Zheng G; Tang H; Xie X
Sci Rep; 2016 Feb; 6():21735. PubMed ID: 26902416
[TBL] [Abstract][Full Text] [Related]
15. Stable shRNA Silencing of Lactate Dehydrogenase A (LDHA) in Human MDA-MB-231 Breast Cancer Cells Fails to Alter Lactic Acid Production, Glycolytic Activity, ATP or Survival.
Mack N; Mazzio EA; Bauer D; Flores-Rozas H; Soliman KF
Anticancer Res; 2017 Mar; 37(3):1205-1212. PubMed ID: 28314283
[TBL] [Abstract][Full Text] [Related]
16. Heat shock factor 1 confers resistance to lapatinib in ERBB2-positive breast cancer cells.
Yallowitz A; Ghaleb A; Garcia L; Alexandrova EM; Marchenko N
Cell Death Dis; 2018 May; 9(6):621. PubMed ID: 29799521
[TBL] [Abstract][Full Text] [Related]
17. MiR-33b inhibits osteosarcoma cell proliferation through suppression of glycolysis by targeting Lactate Dehydrogenase A (LDHA).
Zheng XM; Xu CW; Wang F
Cell Mol Biol (Noisy-le-grand); 2018 Aug; 64(11):31-35. PubMed ID: 30213286
[TBL] [Abstract][Full Text] [Related]
18. FAM3C-YY1 axis is essential for TGFβ-promoted proliferation and migration of human breast cancer MDA-MB-231 cells via the activation of HSF1.
Yang W; Feng B; Meng Y; Wang J; Geng B; Cui Q; Zhang H; Yang Y; Yang J
J Cell Mol Med; 2019 May; 23(5):3464-3475. PubMed ID: 30887707
[TBL] [Abstract][Full Text] [Related]
19. Circular RNA, circular RARS, promotes aerobic glycolysis of non-small-cell lung cancer by binding with LDHA.
Li H; Huang Q; Guo H; Chen X; Li X; Qiu M
Thorac Cancer; 2023 Feb; 14(4):389-398. PubMed ID: 36628612
[TBL] [Abstract][Full Text] [Related]
20. Heat shock factor Hsf1 cooperates with ErbB2 (Her2/Neu) protein to promote mammary tumorigenesis and metastasis.
Xi C; Hu Y; Buckhaults P; Moskophidis D; Mivechi NF
J Biol Chem; 2012 Oct; 287(42):35646-35657. PubMed ID: 22847003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
